A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line
- 1. Department of Surgery, Duke University Medical Center, Durham, NC 27710 (United States)
Description
Osteopontin (OPN) is a highly hydrophilic and negatively charged sialoprotein of ∼298 amino acids which is an important mediator of tumor metastatic behavior. We have previously demonstrated that endotoxin-dependent OPN gene transcription is regulated by a constitutive transcriptional repressor protein, heterogeneous nuclear ribonucleoprotein A/B (hnRNP-A/B). However, in the context of cancer, the role of hnRNP-A/B in the transcriptional regulation of OPN and its metastasis-promoting functions has not been previously studied. We examined hnRNP-A/B in the 4T1 murine mammary epithelial tumor cell line, a thioguanine resistant subline which closely mimics stage IV breast cancer in humans. Our data indicate that hnRNP-A/B p37 binds to the OPN promoter, significantly decreases OPN promoter activity and mRNA levels, ablates OPN protein expression, and inhibits OPN dependent in vitro correlates of metastatic behavior, motility, and invasion. These results are unique and may suggest new therapies to re-establish loco-regional control of cancers
Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2004.07.063;
- PII
- S0006-291X(04)01561-X;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 321
- Journal Issue
- 4
- Journal Page Range
- p. 1010-1016
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 36052608
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- AMINO ACIDS; GENE REGULATION; IN VITRO; MAMMARY GLANDS; METASTASES; NEOPLASMS; PROTEINS; THERAPY; TRANSCRIPTION; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; BODY; CARBOXYLIC ACIDS; DISEASES; GLANDS; MEDICINE; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS
Optional Information
- Copyright
- Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.